First Time Loading...

Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI

Watchlist Manager
Brainstorm Cell Therapeutics Inc Logo
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Watchlist
Price: 0.4599 USD 21.83% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

BCLI Price Targets Summary
Brainstorm Cell Therapeutics Inc

Wall Street analysts forecast BCLI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCLI is 2.55 USD with a low forecast of 2.525 USD and a high forecast of 2.625 USD.

BCLI Lowest Forecast
Wall Street Target
2.525 USD
449% Upside
BCLI Average Forecast
Wall Street Target
2.55 USD
454% Upside
BCLI Highest Forecast
Wall Street Target
2.625 USD
471% Upside
Lowest
Price Target
2.525 USD
449% Upside
Average
Price Target
2.55 USD
454% Upside
Highest
Price Target
2.625 USD
471% Upside
Brainstorm Cell Therapeutics Inc Competitors:
Price Targets
MRNA
Moderna Inc
24% Upside
301047
Sino Biological Inc
48% Upside
CDMO
Avid Bioservices Inc
64% Upside
PHARM
Pharming Group NV
112% Upside
MRNA
Moderna Inc
24% Upside
301047
Sino Biological Inc
48% Upside
CDMO
Avid Bioservices Inc
64% Upside
PHARM
Pharming Group NV
112% Upside
P
214450
PharmaResearch Co Ltd
37% Upside
MOR
MorphoSys AG
14% Downside
302440
SK Bioscience Co Ltd
6% Downside
B
251120
Bio-FD&C Co Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
Brainstorm Cell Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Brainstorm Cell Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Brainstorm Cell Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
What are analyst estimates?

See Also

Summary
BCLI intrinsic value, competitors valuation, and company profile.
DCF Valuation
BCLI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BCLI stock valuation using valuation multiples.
Wall Street Estimates
BCLI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BCLI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCLI's stock price target?
Price Target
2.55 USD

According to Wall Street analysts, the average 1-year price target for BCLI is 2.55 USD with a low forecast of 2.525 USD and a high forecast of 2.625 USD.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.